Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02218866 · ClinicalTrials.gov registry record
The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 205
- Enrollment target
NCT02218866: Completed study, sponsored by University of Utah.
NCT02218866 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 205 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02218866 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
Study Summary
The goal of this research is understand if obesity is a major factor for neuropathy development in patients with and without Type 2 diabetes. This study will examine the relationship between weight, metabolism, and nerve function and regeneration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-12-31 |
What the finished NCT02218866 record still lists
NCT02218866 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02218866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02218866 about?
NCT02218866 is a clinical study titled "The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration". The goal of this research is understand if obesity is a major factor for neuropathy development in patients with and without Type 2 diabetes. This study will examine the relationship between weight, metabolism, and nerve function and regeneration.
What is the current status of trial NCT02218866?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2012-01. Estimated completion is 2017-12-31.
Who is sponsoring clinical trial NCT02218866?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia